浏览量: 119
- 产品名称: Ansamitocin P-3
- 产品货号: CS00033
- 货期: 现货
- 价格与订购: 580
- 数量:
- 规格: 10mg
- 产品信息
- 如何订购
产品描述
Ansamitocin p-3 (Maytansinol isobutyrate, NSC292222) is a potent tubulin polymerization inhibitor with IC50 of 3.4 μM.
靶点活性
Others
细胞实验
Cell lines: A31 and KB. Concentrations: Dissolved in DMSO, final concentrations ~10 μM. Incubation Time: ~24 hours. Method: After synchronized, cells are exposed to various Ansamitocin p-3 concentrations for ~24 hours. Cells are labeled with [3H]thymidine (5 Ci/mM, 1 μCi/mL) in 1 mL medium. After pulse-labeling at 37 °C for 1 hour, the cells on coverslips are fixed with methanol:acetic acid (3:1). The acidsoluble fraction is washed out from the cells, and a liquid scintillation counter is used to determine the radio activity of each coverslip.
激酶实验
Polymerization inhibition assay: After the addition of 1M Tris buffer (pH 8.4, for blank) or 100 μL of various concentrations of Ansamitocin p-3 solution (GTP minus MES buffer), to 400 μL of bovine tubulin solution (1 mg/mL in cold MES buffer), maintained at 0 °C for 10 to 15 minutes, the mixture is warmed in a water bath at 37 °C for 30 to 60 minutes. Tubulin polymerization is followed by an increase in turbidity of the mixture during warming. The turbidity measurement is performed at 460 nm with a Hitachi type 101 spectrophotometer.
动物实验
Animal Models: C57BL/6 mice bearing C1498, or B16 cells, Female DBA/2 mice bearing L1210, P815, or P388 cells, BALB/c mice bearing MOPC-104E cells, and ICR mice bearing sarcoma 180 and EAC. Dosages: about 200 μg/kg. Administration: Administered i.v. or i.p. daily.
别名
Antibiotic C 15003P3 , NSC292222 , Maytansinol isobutyrate , 安丝菌素 P 3 , 安丝菌素 P 3 , NSC292222 , Maytansinol isobutyrate , Antibiotic C 15003P3
分子量
635.14
分子式
C32H43ClN2O9
CAS No.
66584-72-3
存储
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
溶解度
DMSO: 100 mg/ml (157.45 mM)
Ethanol: 55 mg/ml (86.6 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
参考文献
1. Ootsu K, et al. Cancer Res, 1980, 40(5), 1707-1717.
2. Suwanborirux K, et al. Experientia, 1990, 46(1), 117-120.
3. Young DH, et al. J Biomol Screen, 2006, 11(1), 82-89.
4. Edwards A, et al. Dis Model Mech, 2011, 4(4), 496-503.
5. Jubina B Venghateri, et al. PLoS One. 2013 Oct 4;8(10):e75182.
Note
For research use only .
Ansamitocin P-0 下一篇